All In Biotech

Drug Trial Radar · NCT07687459

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Prospective Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Safety of Rentosertib (INS018_055) Administered Orally Over 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Sep 9, 2026

Primary completion

Oct 30, 2029

Study completion Oct 30, 2029

Sponsor

Sponsor type
Industry
First posted
Jul 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Rentosertib (INS018\_055) administered orally in Patients with Idiopathic Pulmonary Fibrosis. The purpose of this study is to evaluate if Rentosertib (INS018\_055) works to treat patients with Idiopathic Pulmonary Fibrosis in adults. It will also learn about the safety of Rentosertib (INS018\_055). In this study, Rentosertib (INS018\_055) will be compared to a placebo (a look-alike substance that contains no drug) to investigate if Rentosertib (INS018\_055) works to treat Idiopathic Pulmonary Fibrosis.

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • INS018_055 tabletsDrug

    Dosage form: Tablets; Frequency of administration: Orally QD. Other Names: Rentosertib

  • PlaceboDrug

    Dosage Form: Tablet; Frequency of administration: Orally QD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the annual rate of forced vital capacity (FVC; mL) decline over 52 weeks.Time frame: Weeks 0,4,12,26,39,52

Locations

47 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Chest Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Fuzhou University Affiliated Provincial Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • The Second Affiliated Hospital of Xiamen Medical College

    Xiamen, Fujian, China · Recruiting

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Not yet recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Recruiting

  • Hebei Medical University Third Hospital

    Shijiazhuang, Hebei, China · Not yet recruiting

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • The People's Hospital of Anyang City

    Anyang, Henan, China · Recruiting

  • Nanyang First People's Hospital

    Nanyang, Henan, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Yichang Central People's Hospital

    Yichang, Hubei, China · Not yet recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • The Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China · Not yet recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China · Not yet recruiting

  • Jiangxi Provincial People' Hospital

    Nanchang, Jiangxi, China · Not yet recruiting

  • The Second Hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'an Medical College

    Xi'an, Shaanxi, China · Recruiting

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Recruiting

  • Introduction of the First Affiliated Hospital of Shandong First Medical University

    Jinan, Shandong, China · Not yet recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Shanghai Pulmonary Hospital Affiliated to Tongji University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Not yet recruiting

  • Yuncheng Central Hospital

    Yuncheng, Shanxi, China · Not yet recruiting

  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Not yet recruiting

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China · Not yet recruiting

  • Tianjin Chest Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China · Not yet recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.